Contraception
📧 Sign up to get email alerts when something new happens for Contraception.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2022-02-02FDA Approved: NORGESTIMATE AND ETHINYL ESTRADIOL — Supplemental Application (Naari Pte Limited)
FDA approves a supplemental application for the generic combined oral contraceptive Norgestimate and Ethinyl Estradiol from Naari Pte Limite…
-
FDA approval · 2022-01-28FDA Approved: NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for a combined oral contraceptive containing norethindrone, ethinyl estradiol, and ferrous fumar…
-
FDA approval · 2022-01-27FDA Approved: TRI-SPRINTEC — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved Teva Pharmaceuticals' supplemental application for Tri-SprinTEC, a generic combined oral contraceptive containing norgestim…
-
CLINICAL_TRIALS trial_result · 2022-01-26Clinical Trial Update: A Study to Evaluate Injection Pain and Local Tolerability Following Subcutaneous (SC) Administration of TV-46046 [Phase 1]
Phase 1 study assessing injection pain and local tolerability after subcutaneous administration of TV-46046 in contraception.
-
FDA approval · 2022-01-25FDA Approved: VYLIBRA — Supplemental Application (Afaxys Pharma, LLC)
FDA approved a supplemental application for VYLIBRA (norgestimate and ethinyl estradiol) from Afaxys Pharma, LLC, expanding its labeling for…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA label_change · 2022-01-25FDA Approved: TRI-MILI — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for TRI-MILI (norgestimate and ethinyl estradiol) from Aurobindo Pharma Limited, updating the produc…
-
FDA approval · 2022-01-21FDA Approved: TRI-LO-MILI — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for TRI-LO-MILI (norgestimate and ethinyl estradiol) by Aurobindo Pharma Limited, authorizing its co…
-
CLINICAL_TRIALS trial_result · 2021-12-10Clinical Trial Update: Comparative Efficacy of Lidocaine Spray Versus Vaginal Misoprostol in IUD Insertion [Phase 3]
Phase 3 trial comparing lidocaine spray to vaginal misoprostol for IUD insertion has completed.
-
CLINICAL_TRIALS research · 2021-10-28Clinical Trial Update: A Study to Compare the Menstrual Bleeding Profile Among Jaydess® and Copper Intrauterine Device (IUD) Users. COLIBRI STUDY (Copper and Levonorgestrel IUD Barcelona Research Initiative). [Phase 4]
A Phase 4 study comparing menstrual bleeding profiles between Jaydess and copper IUD users, completed.
-
CLINICAL_TRIALS trial_result · 2021-09-16Clinical Trial Update: A Clinical Investigation to Assess the Performance of a Polyurethane Condom Versus a Latex Condom in Healthy Monogamous Couples [Phase 4]
Phase 4 clinical trial comparing polyurethane vs latex condoms in healthy couples; completed study evaluating performance for pregnancy and …
-
FDA approval · 2021-08-18FDA Approved: JUNEL 21 DAY — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for Junel 21 Day (norethindrone acetate and ethinyl estradiol) from Teva Pharmaceuticals USA, Inc.
-
FDA approval · 2021-08-18FDA Approved: JUNEL FE 28 DAY — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for JUNEL FE 28 DAY, a combined oral contraceptive containing norethindrone acetate, ethinyl estradi…
-
FDA approval · 2021-07-20FDA Approved: NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL, AND FERROUS FUMARATE — Original Application (Amneal Pharmaceuticals NY LLC)
FDA approves a generic combination oral contraceptive containing norethindrone acetate, ethinyl estradiol, and ferrous fumarate under an Ori…
-
CLINICAL_TRIALS trial_result · 2021-06-29Clinical Trial Update: Synthetic vs Natural Estrogen in Combined Oral Contraception [Phase 4]
Phase 4 trial comparing synthetic versus natural estrogen in combined oral contraception completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-06-03Clinical Trial Update: Effect of Norgestrel 75 mcg on Cervical Mucus and Ovarian Activity During Perfect Use, After One Delayed Intake and After a Missed Pill [Phase 2]
Phase 2 trial evaluating the effect of Norgestrel 75 mcg on cervical mucus and ovarian activity under perfect-use, after a delayed intake, a…
-
CLINICAL_TRIALS trial_result · 2021-05-07Clinical Trial Update: Comparative Safety and Efficacy of Vaginal Misoprostol Versus Lidocaine-prilocaine Cream in Levonorgestrel IUD Insertion [Phase 3]
A Phase 3 trial comparing vaginal misoprostol to lidocaine-prilocaine cream for safety and efficacy during levonorgestrel IUD insertion has …
-
CLINICAL_TRIALS trial_result · 2021-04-13Clinical Trial Update: Clinical Study of Depo Provera Comparing Lay Health Workers and Clinically-trained Health Workers [EARLY_Phase 1]
Early-phase clinical trial comparing lay health workers to clinically-trained health workers in contraception.
-
CLINICAL_TRIALS trial_result · 2021-04-08Clinical Trial Update: Study Investigating the Efficacy and Safety of a Contraceptive Patch for 13 Cycles [Phase 3]
Phase 3 study update on the efficacy and safety of a contraceptive patch for 13 cycles has been completed.
-
CLINICAL_TRIALS trial_result · 2021-04-08Clinical Trial Update: US Ovulation Inhibition Study in Obese Women [Phase 2]
Phase 2 clinical trial update evaluating ovulation inhibition in obese women for contraception.
-
CLINICAL_TRIALS trial_result · 2021-04-08Clinical Trial Update: Safety and Contraceptive Efficacy of an Intravaginal Ring With LNG (Levonorgestrel) Over One Year in Healthy Women [Phase 3]
Phase 3 trial update on safety and contraceptive efficacy of an intravaginal ring delivering levonorgestrel over one year in healthy women.
-
CLINICAL_TRIALS trial_result · 2021-04-08Clinical Trial Update: Essure (Model ESS310) Placement Rate Study [Phase 3]
A Phase 3 clinical trial update on Essure (ESS310) placement rate for contraception has completed.
-
CLINICAL_TRIALS trial_result · 2021-01-22Clinical Trial Update: Patient Compliance With Long-Acting Reversible Contraception Administration [NA]
Clinical trial update on patient compliance with long-acting reversible contraception; status terminated with posted results in 2021.
-
FDA approval · 2021-01-13FDA Approved: ASHLYNA — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
The FDA approved a supplemental application for ASHLYNA, a combined oral contraceptive containing levonorgestrel and ethinyl estradiol, manu…
-
CLINICAL_TRIALS trial_result · 2020-11-16Clinical Trial Update: Improving Reproductive Health for Women in Opioid Medication-Assisted Treatment (OMAT) [NA]
Clinical trial update on improving reproductive health for women in opioid medication-assisted treatment; study completed with results poste…
-
CLINICAL_TRIALS trial_result · 2020-11-13Clinical Trial Update: Smoking, Sex Hormones, and Pregnancy [Phase 2]
Phase 2 clinical trial update on smoking, sex hormones, and pregnancy; results posted after completion.